ETFs & Funds
This user currently has no profile.
rmyers3000 has yet to provide a bio.
Stocks - long
Currently, there is no company profile for rmyers3000.
Currently, there are no blog details for rmyers3000.
Currently, there are no book details for rmyers3000.
You mention in your article...
Vical's Allovectin: Update On The Phase III Trial
No, the data is not due 2Q2...
Vical: 2012 Should Be A Huge Year
Can Novartis still file for...
The Long Case For Emisphere: Expecting A Buyout
Did anyone see the study po...
Emisphere: A Call Option On Novartis-Supported ...
Hi JosephAny news from the ...
What's Bad For Bisphosphonates Is Good For Emis...